Neurotrophic keratopathy and ocular surface disease

Article
Conference|Twin Cities Ocular Surface Disease Symposium

Ahmad Fahmy, OD, FAAO, explains that the line in the sand for the ocular surface is the corneal epithelium. He outlines his talk at Dry Eye Everything Virtual Symposium which looks at how corneal nerve sensation intersects with the health of the ocular surface.

Related: How to start treating dry eye

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Subscribe Now!
Recent Videos
Selina McGee, OD, shares what she wants to see in future State of Dry Eye surveys and how this year's results will affect her patient care.
Selina McGee, OD, FAAO, Dipl ABO, shares key takeaways and a personal anecdote relating to the State of Dry Eye survey results.
Reviewing the State of Dry Eye Survey with Selina McGee, OD, FAAO, Dipl ABO.
Jacob Lang, OD, FAAO, details early symptom relief demonstrated in as early as day 1 during AOA's Optometry's Meeting 2025.
Mitch Ibach, OD, FAAO, details the importance to unveiling the underlying cause of dry eye in a CCS 2025 presentation.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, ponders what she would like to see develop as both a researcher and a clinician in the dry eye space.
Bridgitte Shen Lee, OD, FAAO, FBCLA, FEAOO, discussed research that utilized IQVIA longitudinal prescription claims data from September through November 2023, coinciding with Miebo's FDA approval in September.
Dr Julie Poteet reports on patient-reported outcomes using lipid-containing artificial tear
Elise Kramer, OD, FAAO, FSLS, describes her take on a multidisciplinary approach to dry eye
Cecelia Koetting, OD, FAAO, DipABO, weighs in on patient assessments, staining pattern insights, and diagnostic tips for patients who may have dry eye disease.
Related Content
FDA accepts Aldeyra Therapeutics' new drug application for reproxalap for review.

FDA accepts for review Aldeyra Therapeutics’ resubmitted new drug application for reproxalap

Martin David Harp, Editor, Ophthalmology Times
July 17th 2025
Article
Split image of dry eye before and after treatment Image credit: ©Alessandro Grandini - adobe.stock.com

Optometrists, organizations provide insight for State of Dry Eye survey

Jordana Joy, Associate Editor;Jessilin Quint, OD, MBA, MS, FAAO;Grace Koennecke
August 16th 2024
Podcast
Woman administering eye drops Image credit: AdobeStock/TatjanaMeininger

Bausch + Lomb's new dry eye survey data usher in campaign for patient education

Jordana Joy, Associate Editor
July 1st 2025
Article
Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

Podcast: TearRestore CEO, Ken DauSchmidt, reviews new open-eye warm compress treatment

Ken DauSchmidt;Brooke Henson, Editor
September 24th 2021
Podcast
Aldeyra submits third reproxalap new drug application for the treatment of dry eye disease. - ©naka—stock.adobe.com

Aldeyra submits third reproxalap new drug application for the treatment of dry eye disease

Martin David Harp, Editor, Ophthalmology Times
June 17th 2025
Article
Woman administering eye drops Image credit: AdobeStock/AndreyPopov

Bausch + Lomb launch Blink Nourish Lubricating eye drops and Blink Boost Lubricating eye drops in the US for dry eye

Jordana Joy, Associate Editor
June 4th 2025
Article
© 2025 MJH Life Sciences

All rights reserved.